| Bioactivity | DHX9-IN-19 (compound 3) is an orally active and potent inhibitor of DHX9. DHX9-IN-19 plays an important role in cancer research[1]. |
| CAS | 2973400-78-9 |
| Formula | C20H21ClN4O4S2 |
| Molar Mass | 480.99 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Accent Therapeutics, Inc. Assays for monitoring inhibition of RNA helicase DHX9 by measuring the level of Alu-mediated circular RNA in relation to cancer treatment. World Intellectual Property Organization, WO2024220373 A1 2024-10-24 |
DHX9-IN-19
CAS: 2973400-78-9 F: C20H21ClN4O4S2 W: 480.99
DHX9-IN-19 (compound 3) is an orally active and potent inhibitor of DHX9. DHX9-IN-19 plays an important role in cancer r
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.